The protic and Lewis acid promoted cyclization reactions of tethered furan-4,5-dihydroxypiperid-2-ones, furan-4,5-diacetoxypiperid-2-ones and furan-3,4-diacetoxypyrrolid-2-ones, via their corresponding Nacyliminium ion intermediates, have been studied. In the case of the furan-4,5-dihydroxypiperid-2-one 2a and its diacetate derivative 2b, macrocyclic products were formed from an initial intermolecular reaction between 2a or 2b, via the nucleophilic C5 furan carbon, and their corresponding N-acyliminium ion intermediates. When the furan C5 position of 2b was blocked by substitution with bromine then TFA or Sc(OTf)3 catalysed cyclization reactions gave a spirotricyclic product (a 5-6-6-tricycle) in a highly diastereoselective manner. Cyclization of the analogous C5-Br-furan-pyrrolidone 29 with TFA resulted in a related spirotricyclic (a 5-6-5 tricycle) product. Attempts to prepare an analogous azepine system, a 5-7-5 tricycle, were not successful. Cyclization reactions of the C5-PhS-furan-or C5-phenylsulfonyl-pyrrolidone analogues of 29 with TFA were also not successful. Cyclization of the analogous C5-Br-furan-pyrrolidone 29 with TFA resulted in a related spirotricyclic (a 5-6-5 tricycle) product. Attempts to prepare an analogous azepine system, a 5-7-5 tricycle, were not successful. Cyclization reactions of the C5-PhS-furanor C5-phenylsulfonyl-pyrrolidone analogues of 29 with TFA were also not successful.
Introduction
As part of a study aimed at the synthesis of the pyrido[1, 2-a] Tanis   4 . Martin found that the LiClO 4 promoted cyclization reactions of the highly activated TIPSO substituted furan substrates 8 gave exclusively the spirotricyclic products 9a,b (Scheme 2) while Tanis disclosed the formation of linearly fused tricyclic adducts 11a,b from substrates 10 in which the furan ring was only substituted at the tethered position (Scheme 3).
Unfortunately, attempts by the latter group to prepare an azepine system 12b, as desired by us, were unsuccessful (Scheme 3). However, a more recent report by Padwa showed that the formation of the azepine ring of 14 was possible employing a tethered 4-ethyl substituted furan 13 (Scheme 4). 5 With this information in mind we decided to investigate the effect of various substituents on the furan ring on the cyclization reactions of the furan-aminols 2a-c. 
Results and discussion
The furyl amine 17, that was required for the synthesis of 2a, was synthesized from commercially available nitrile 15 in 81% yield over two steps as shown in Scheme 5. 6 Amine 17 was coupled with the acid chloride prepared from L-glutamic acid 7 to give amide 18 in 80% yield. Potassium tert-butoxide catalysed rearrangement of 18 provided glutarimide 19 in high yield (90%). 8 The C2 carbonyl group of 19 was regioselectively reduced using NaBH 4 to give the diol 2a. 9 With the cyclization precursor in hand we further subjected 2a to various Lewis acid or acid catalysed reaction conditions. Long at rt for 2 d the macrocycle 21 was isolated in 29% yield after purification by column chromatography (Scheme 7). In this case, the furan moiety of 2a acted as a nucleophile, in an intermolecular sense at C5, with the N-acyliminium ion A. While 20 was also likely to be formed initially in this reaction it would be expected to be in equilibrium with the N-acyliminium ion A and thus 20 would be slowly transformed into the more stable product 21. Our attempts to achieve the transformation of 20 to 21, however, were not successful. For example, exposure of 20 to BF 3 ·Et 2 O resulted in a complex mixture of products. The yield of this macrocycle forming reaction was found to be better when carried out on the diacetate derivative 2b. This substrate gave the macrocycle 22 in 58% To avoid intermolecular reactions and thus favour intramolecular cyclization, we synthesized the cyclization precursor 2c, in which both the potentially nucleophilic sites, the C5-hydroxyl group on the piperidinone ring and the C5 position on the furan ring were protected and blocked, respectively. We chose to block the C5 position of the furan moiety with bromine hoping that this weak electron withdrawing group would not dramatically reduce the nucleophilicity of the furan towards cyclization. and the butenolide oxygen (Scheme 2). 3 We also investigated if this reaction could be used to synthesize a tricyclic spirobutenolide with a 5-6-5 tricyclic ring skeleton by subjecting the tethered furanpyrrolidinone 29 to acidic conditions. Compound 29 was synthesized in a similar way as Our attempts to preparing a spirocyclic 5-7-5 tricyclic ring structure using this methodology, akin to that found in many croomine-type Stemona alkaloids, [11] [12] [13] [14] have not been successful. 
Conclusions
We have studied the protic and Lewis acid catalysed cyclization reactions of tethered furan-4,5-dihydroxypiperid-2-ones, furan-4,5-diacetoxypiperid-2-ones and furan-3,4-diacetoxypyrrolid-2-ones via their corresponding N-acyliminium ion intermediates. In the case of the furan-piperidone 2a and its diacetate derivative 2b a macrocyclic product arose from an initial intramolecular reaction between 2a or 2b, via the nucleophilic C5
furan carbon, and their corresponding N-acyliminium ion intermediates. When the furan C5 position of 2b was blocked by substitution with a bromine atom then TFA or Sc(OTf) 3 catalysed cyclization gave a spirotricyclic product (a 5-6-6-tricycle) in a highly diastreoselective manner. The alternative cyclization product having the linearly fused tricyclic furan system required for the synthesis of stemocurtisine was not produced.
Cyclization of the analogous C5-Br-furan-pyrrolidone 29 with TFA resulted in a related spirotricyclic (a 5-6-5 tricycle) product. Attempts to prepare an analogous azepine system, a 5-7-5 tricycle, were not successful. Cyclization reactions of the C5-PhS-furanpyrrolidone or C5-phenylsulfonyl analogues of 29 with TFA were also not successful.
The former case may have been deactivated to cyclization by protonation of the sulfur atom.
Experimental

General
All IR spectra were run as neat samples. All NMR spectra were run at 500 MHz ( 
3-(Furan-2-yl)propanenitrile (16).
17
A solution of 15 (1.00 g, 8.40 mmol) in ethanol (10 mL) was flushed with N 2 for 5 min. 
3-(Furan-2-yl)propan-1-amine (17)
. 6 To a mixture of lithium aluminium hydride (471 mg, 12.3 mmol) in THF (10 mL) at 0 °C was added dropwise a solution of 16 (500 mg, 4.13 mmol) in THF (5 mL) under a N 2
atmosphere. The reaction mixture was stirred at the same temperature for 1 h. The reaction mixture was cooled to −10 °C followed by the dropwise addition of water (2 mL) and 10 % NaOH (2 mL). The reaction mixture was slowly warmed to rt and then 
(R)-N-(3-(Furan-2-yl)propyl)-5-oxotetrahydrofuran-2-carboxamide (18).
To a solution of 17 (500 mg, 4.00 mmol) in CH 2 Cl 2 (5 mL) was added triethylamine 
(S)-1-(3-(Furan-2-yl)propyl)-3-hydroxypiperidine-2,6-dione (19).
Compound 18 (100 mg, 0.421 mmol) was dissolved in THF (5 mL) and the reaction mixture was cooled to −78 °C. Potassium tert-butoxide (24 mg, 0.210 mmol) was added over 10 min. in small portions to the reaction mixture. The reaction mixture was slowly warmed to −40 °C and stirred at the same temperature until TLC analysis showed completion of the reaction. The reaction mixture was cooled to −78 °C and then quenched with a saturated solution of NaHCO 3 (2 mL). The reaction mixture was then diluted with water (5 mL) and then extracted with EtOAc (3 × 25 mL 
(5S)-1-(3-(Furan-2-yl)propyl)-5,6-dihydroxypiperidin-2-one (2a).
Compound 19 (190 mg, 0.801 mmol) was dissolved in EtOH/CH 2 Cl 2 (8:2, 5 mL) and the reaction mixture was cooled to −40 °C followed by addition of NaBH 4 (213 mg, 5.61 mmol) and the reaction mixture stirred at the same temperature for 1 h. The reaction was quenched with a saturated solution of NaHCO 3 (5 mL) and the reaction mixture was warmed to rt. The reaction mixture was extracted with EtOAc (3 × 25 mL), and the combined extracts were dried (MgSO 4 ) and the solvent was removed under reduced pressure. The residue was purified by FCC over silica gel using a gradient of 0:100- 
(3S)-1-(3-(Furan-2-yl)propyl)-6-oxopiperidine-2,3-diyl diacetate (2b).
To 
Macrocycle 22.
To a solution of 2b (60 mg, 0.185 mmol) in acetonitrile (3 mL) was added BF 3 ·OEt 2 (0.023 mL, 0.185 mmol) and the reaction was stirred at rt for 16 h. The solvent was removed under reduced pressure and the dark brown residue was subjected to FCC over silica gel using a gradient of 0:100 
Synthesis of macrocycle 21 from 22.
To a solution of 22 (25 mg, 0.047 mmol) in MeOH (3 mL) was added KOH (26 mg, 0.470 mmol) and the reaction mixture was stirred at rt for 16 h. The solvent was removed under reduced pressure and the crude residue was purified by FCC over silica gel using a gradient of 0:100−20:80 MeOH/EtOAc to give 21 as a light yellow solid (21 mg, 98%). This compound was identical to that obtained above from cyclization of 2a.
(S)-1-(3-(5-Bromofuran-2-yl)propyl)-3-hydroxypiperidine-2,6-dione (23).
To a stirred solution of 19 (100 mg, 0.421 mmol) in DMF (5 mL) at 0 °C was added NBS (75 mg, 0.421 mmol) and the reaction mixture was stirred at the same temperature for 1 h. The reaction was quenched with a saturated solution of NaHCO 3 (5 mL) and then extracted with EtOAc (3 × 25 mL). The combined extracts were washed with water (3 × 20 mL) and then dried (MgSO 4 ). The solvent was removed under reduced pressure and the residue was subjected to FCC over silica gel using a gradient of 10:90 
(5S)-1-(3-(5-Bromofuran-2-yl)propyl)-5,6-dihydroxypiperidin-2-one (24).
The title compound was synthesised from 23 (100 mg, 0.31 mmol) using the method described for the synthesis of 2a. 
(3S)-1-(3-(5Bromofuran-2-yl)propyl)-6-oxopiperidine-2,3-diyl diacetate (2c).
Using the method described for the synthesis of 2b the title compound was isolated as colourless oil (59 
(S)-1-(3-(Furan-2-yl)propyl)-3-hydroxypyrrolidine-2,5-dione (26).
To a solution of 17 (500 mg, 4.00 mmol) in xylene (15 mL 
(S)-1-(3-(5-Bromofuran-2-yl)propyl)-3-hydroxypyrrolidine-2,5-dione (27).
The title compound was synthesized from 26 (120 mg, 0.538 mmol) using the method 
(4S)-1-(3-(5-Bromofuran-2-yl)propyl)-4,5-dihydroxypyrrolidin-2-one (28).
The title compound was synthesized from 27 (100 mg, 0.33 mmol) using the method 
(3S)-1-(3-(5-Bromofuran-2-yl)propyl)-5-oxopyrrolidine-2,3-diyl diacetate (29).
The title compound was synthesized from 28 (60 mg, 0.154 mmol) using the same method used for the synthesis of compound 2b as a colourless oil (63 mg, 82%); R f : 0.48 
(1'S,2R)-3',5-dioxo-2',3',5',6',7',8a'-hexahydro-1'H,5H-spiro[furan-2,8'-indolizin]-1'-yl acetate (30).
Compound 30 was synthesized from 29 (42 mg, 0.158 mmol) using the method (method 
(E) and (Z)-3-(5-Bromofuran-2-yl)acrylonitrile (31).
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To a solution of 15 (1.5 g, 12.6 mmol) in DMF (15 mL 
(E)-3-(5-(Phenylthio)furan-2-yl)acrylonitrile (32).
To a solution of 31 (1.00 g, 5.05 mmol) in methanol (20 mL) was added sodium thiophenolate (2.00 g, 15.1 mmol) and the reaction mixture heated at reflux for 16 h under a N 2 atmosphere. Water (10 mL) was added and the mixture was extracted with EtOAc (3 × 50 mL). The combined extracts were dried (MgSO 4 ) and the solvent was removed under reduced pressure. ) 288.0478, found 228.0501.
3-(5-(Phenylthio)furan-2-yl)propanenitrile (33).
To a solution of 32 (500 mg, 2.20 mmol) in MeOH (10 mL 
(S)-3-Hydroxy-1-(3-(5-(phenylthio)furan-2-yl)propyl)pyrrolidine-2,5-dione (35).
(4S)-4,5-Dihydroxy-1-(3-(5-(phenylthio)furan-2-yl)propyl)pyrrolidin-2-one (36).
The title compound was synthesised from 35 (80 mg, 0.256 mmol) using the same method described for the synthesis of 2a (40 mg, 50%) and in a diastereomeric ratio of 
(3S)-5-Oxo-1-(3-(5-(phenylthio)furan-2-yl)propyl)pyrrolidine-2,3-diyl diacetate (37).
The title compound was 37 synthesised from 36 (30 mg, 0.071 mmol) using the same method described for the synthesis of 2b (34 mg, 91%). and in a diastereomeric ratio of 
(S)-3-Hydroxy-1-(3-(5-(phenylsulfonyl)furan-2-yl)propyl)pyrrolidine-2,5-dione (38).
To a solution of 35 (50 mg, 0.151 mmol) in acetic acid (5 mL) was added hydrogen peroxide (30% solution in water, 0.5 mL) and the reaction mixture was stirred at rt for 2 d. A saturated solution of NaHCO 3 (5 mL) was slowly added and the rmixture was extracted with EtOAc (3 ×20 mL). 
(4S)-4,5-Dihydroxy-1-(3-(5-(phenylsulfonyl)furan-2-yl)propyl)pyrrolidin-2-one (39).
The title compound was synthesized from 38 (50 mg, 0.137 mmol) using the method described for the synthesis of 26 (27 mg, 54%) and in a diastereomeric ratio of 10:0.7;
IR v max (cm 
(3S)-5-Oxo-1-(3-(5-(phenylsulfonyl)furan-2-yl)propyl)pyrrolidine-2,3-diyl diacetate (40).
The title compound was synthesised from 39 (25 mg, 0.055 mmol) using the same , 1804 unique data (θ = 2.6-27.5°), R = 0.029 [for 1650 with I > 2.0σ(I)]; Rw = 0.074 (all data), S = 1.01.
Structure determination.
Images were measured on a Nonius Kappa CCD diffractometer (MoKα, graphite monochromator, λ = 0.71073 Å) and data extracted using the DENZO package. Structure solution was by direct methods (SIR92). 19 The structure was refined using the CRYSTALS program package. 20 Atomic coordinates, bond lengths and angles, and
